Aion Therapeutic Inc.

Recent News

  • Aion Therapeutic Announces Closing of Non-Brokered Private Placement

    Toronto, Ontario--(Newsfile Corp. - June 11, 2021) - Aion Therapeutic Inc. (CSE: AION) ("Aion Therapeutic" or the "Company") is pleased to announce the closing of a non-brokered private placement through the issuance of 16,994,475 units (each, a "Unit") at a price of $0.0875 per Unit for gross proceeds of $1,487,016.56 (the "Offering"). The proceeds of the Offering will be used by the Company for general working capital purposes.Each Unit is comprised of one common share (each, a "Common Share")...

    2021-06-11 5:45 PM EDT
  • Aion Therapeutic Opening the First International Treatment Center for Psychedelic Psychiatry in Jamaica; Hires Leading Psychiatrist as Medical Director

    Toronto, Ontario--(Newsfile Corp. - February 23, 2021) - Aion Therapeutic Inc. (CSE: AION) ("Aion Therapeutic" or the "Company") announced today the opening of the Aion International Center for Psychedelic Psychiatry in Jamaica. The Center will initially specialize in the use of psilocybin for the treatment of addiction (tobacco, alcohol, and other drug misuse), depression and anxiety associated with life-threatening illnesses, treatment-resistant depression, and major depressive disorder (MDD). In addition, the Center will be studying the effectiveness of psilocybin as...

    2021-02-23 10:58 AM EST
  • Aion Therapeutic Announces Closing of Non-Brokered Private Placement

    Toronto, Ontario--(Newsfile Corp. - February 22, 2021) - Aion Therapeutic Inc. (CSE: AION) ("Aion Therapeutic" or the "Company") is pleased to announce the closing of a non-brokered private placement through the issuance of 6,666,333 units ("Units") at a price of $0.075 per Unit for gross proceeds of approximately $499,975 (the "Offering"). The proceeds of the Offering will be used for general working capital purposes.Each Unit is comprised of one common share ("Common Share") of the Company and one-half of one...

    2021-02-22 6:30 PM EST
  • Aion Therapeutic Grants Stock Options; Announces Management Change

    Toronto, Ontario--(Newsfile Corp. - February 3, 2021) - Aion Therapeutic Inc. (CSE: AION) ("Aion Therapeutic" or the "Company") announced today that it has granted and issued options for the purchase of up to 4,000,000 common shares of the Company to a number of the Company's officers, directors and consultants. The stock options were granted on February 2, 2021 in accordance with the Company's stock option plan and are exercisable for a period of three years from the date of...

    2021-02-03 6:24 PM EST
  • Aion Therapeutic Announces Closing of Non-Brokered Private Placement

    Toronto, Ontario--(Newsfile Corp. - December 23, 2020) -  Aion Therapeutic Inc. (CSE: AION) ("Aion Therapeutic" or the "Company") is pleased to announce the closing of a non-brokered private placement through the issuance of 15,384,615 units ("Units") at a price of $0.065 per Unit for gross proceeds of $1,000,000 (the "Offering"). The proceeds of the Offering will be used for general working capital purposes.Each Unit is comprised of one common share ("Common Share") of the Company and one-half of one Common...

    2020-12-23 5:05 PM EST
  • Aion Therapeutic Amends Convertible Debentures

    Toronto, Ontario--(Newsfile Corp. - October 30, 2020) -  Aion Therapeutic Inc. (CSE: AION) ("Aion Therapeutic" or the "Company") announced today that the Company has entered into a convertible debenture extension and amendment agreement (the "Amending Agreement") dated October 29, 2020 with Quinsam Capital Corporation (the "Lender"). The Amending Agreement amends certain terms of the 10% convertible debenture dated November 1, 2017 in the principal amount of $262,500 and the 10% convertible debenture dated December 10, 2017 in the principal amount...

    2020-10-30 4:48 PM EDT
  • Aion Therapeutic Names James W.G. Thompson, Ph.D. as President

    Toronto, Ontario--(Newsfile Corp. - October 21, 2020) - Aion Therapeutic Inc. (CSE: AION) ("Aion Therapeutic" or the "Company") is pleased to announce that the Company has named James W.G. Thompson, Ph.D. as its new president.Dr. Thompson is an accomplished neuroscientist and healthcare technology entrepreneur with over 20 years industry experience. Most recently he co-founded Evoke Neuroscience, Inc., a healthcare technology company founded in 2009 and focused on aiding diagnosis and therapy for neurological disorders. Dr. Thompson served on the Board...

    2020-10-21 9:15 AM EDT
  • Aion Therapeutic Announces Closing of Non-Brokered Private Placement

    Toronto, Ontario--(Newsfile Corp. - September 18, 2020) -  Aion Therapeutic Inc. (CSE: AION) ("Aion Therapeutic" or the "Company") is pleased to announce the closing of a non-brokered private placement through the issuance of 9,090,907 units ("Units") at a price of $0.055 per Unit for gross proceeds of approximately $500,000 (the "Offering"). The proceeds of the Offering will be used for general working capital purposes.Each Unit is comprised of one common share ("Common Share") of the Company and one-half of one...

    2020-09-18 5:15 PM EDT